NCT00383578View on ClinicalTrials.gov

Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

335

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

May 31, 2008

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Vildagliptin 100 mg qd

DRUG

Metformin 1500 mg daily

Trial Locations (2)

Unknown

Investigative Centers, Nuremberg

Novartis Pharmaceuticals, Basel

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY